USP4 and osteosarcoma: Sarri et al. [87] confirmed that in osteosarcoma cells, USP4 and USP17 significantly inhibit the ubiquitination of platelet-derived growth factor receptor β (PDGFRβ) and are able to remove polyubiquitin chains linked to Lys63 and Lys48 on the receptor.